Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1998; 32:1680-1686
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andrews, T. C.
Right arrow Articles by Stone, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andrews, T. C.
Right arrow Articles by Stone, P. H.

Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunction

Thomas C. Andrews, MD, FACC*, John D. Parker, MD, FACC{dagger}, Sue Jacobs, PhD{ddagger}, Richard Friedman, PhD§, Nancy Cummings, RN||, Gail MacCallum, BS, Finn Mannting, MD# **, Geoffrey H. Tofler, MD, FACC** {dagger}{dagger}, William Carlson, MD, FACC¶ **, James E. Muller, MD, FACC{ddagger}{ddagger} and Peter H. Stone, MD, FACC¶ **

* Department of Internal Medicine, Cardiology Division, University of Texas Southwestern Medical Center, Dallas, Texas, USA
{dagger} Division of Cardiology, Mount Sinai Hospital, University of Toronto, Toronto, Canada
{ddagger} Department of Counseling, University of North Dakota, Grand Forks, North Dakota, USA
§ Department of Psychiatry, State University of New York at Stony Brook, USA
|| Department of Surgery, Brigham and Women’s Hospital, Boston, Massachusetts, USA
Cardiovascular Division/Department of Medicine, Brigham and Women’s Hospital, Boston, USA
# Department of Nuclear Medicine, Brigham and Women’s Hospital, Boston, USA
** Harvard Medical School, Boston, USA
{dagger}{dagger} Institute for Prevention of Cardiovascular Disease, Deaconess Hospital, Boston, USA
{ddagger}{ddagger} Division of Cardiovascular Medicine, University of Kentucky, Louisville, Kentucky, USA



View larger version (14K):

[in a new window]
 
Figure 1 Change in global ejection fraction: Subjects with a decline of ≥5% on placebo (n = 5). Boxes indicate mean values, with error bars demonstrating 1 SE unit. EF = left ventricular ejection fraction.

 


View larger version (19K):

[in a new window]
 
Figure 2 Change in wall-motion score and regional ejection fraction: Comparison of region with largest decrease during placebo phase for all 15 subjects. See text for explanation of wall-motion scoring and Table 2 for absolute values for wall motion and regional EF. Pairwise comparisons are not statistically significant unless otherwise indicated. EF = left ventricular ejection fraction. {blacksquare} = placebo; {square} = nifedipine; {cjs2110} = atenolol.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement